Literature DB >> 12895403

Cerebral Venous Thrombosis.

Valérie Biousse1, Frank Tong, Nancy J. Newman.   

Abstract

Because of its wide range of presentations, its highly variable mode of onset, its numerous causes, and its unpredictable outcome, cerebral venous thrombosis (CVT) remains a diagnostic and therapeutic challenge. Treatment of CVT consists primarily of symptomatic treatment of seizures and intracranial hypertension, antithrombotics, and etiologic treatment whenever possible. Heparin remains the first line of treatment for CVT; although its systematic use remains debated, recent studies have confirmed its safety even in patients with large hemorrhagic infarctions. The addition of local thrombolysis is indicated for patients with clinical worsening related to extension of the venous thrombosis, despite adequate anticoagulation and optimal symptomatic and etiologic treatment. In contrast to arterial stroke, complete recovery of prolonged or severe neurologic deficit is possible, justifying initiation of anticoagulation and eventually thrombolysis, even when the clinical situation seems desperate. New techniques using mechanical devices disrupting the clot may be used in addition to thrombolysis in rare cases. Ventricular drainage is indicated in cases of cerebellar infarction or deep venous thrombosis associated with hydrocephalus. Decompressive craniotomy may be performed acutely in patients with untractable intracranial hypertension and herniation.

Entities:  

Year:  2003        PMID: 12895403     DOI: 10.1007/s11940-003-0031-y

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  46 in total

1.  Cerebral Venous Thrombosis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

2.  Direct thrombolysis of superior sagittal sinus thrombosis with coexisting intracranial hemorrhage.

Authors:  J R Rael; W W Orrison; N Baldwin; J Sell
Journal:  AJNR Am J Neuroradiol       Date:  1997-08       Impact factor: 3.825

3.  Direct thrombolytic therapy for superior sagittal sinus thrombosis.

Authors:  R T Higashida; E Helmer; V V Halbach; G B Hieshima
Journal:  AJNR Am J Neuroradiol       Date:  1989 Sep-Oct       Impact factor: 3.825

4.  Emergent decompressive craniectomy in patients with fixed dilated pupils due to cerebral venous and dural sinus thrombosis: report of three cases.

Authors:  R Stefini; N Latronico; C Cornali; F Rasulo; A Bollati
Journal:  Neurosurgery       Date:  1999-09       Impact factor: 4.654

5.  Acute thrombosis of the intracranial dural sinus: direct thrombolytic treatment.

Authors:  F Y Tsai; R T Higashida; V Matovich; K Alfieri
Journal:  AJNR Am J Neuroradiol       Date:  1992 Jul-Aug       Impact factor: 3.825

6.  Emergency endovascular treatment of cerebral sinus thrombosis with a rheolytic catheter device.

Authors:  C R Gomez; V K Misra; J B Terry; R Tulyapronchote; M S Campbell
Journal:  J Neuroimaging       Date:  2000-07       Impact factor: 2.486

7.  Heparin treatment in sinus venous thrombosis.

Authors:  K M Einhäupl; A Villringer; W Meister; S Mehraein; C Garner; M Pellkofer; R L Haberl; H W Pfister; P Schmiedek
Journal:  Lancet       Date:  1991-09-07       Impact factor: 79.321

8.  Cerebral venous thrombosis complicated by hemorrhagic infarction: factors affecting the initiation and safety of anticoagulation.

Authors:  D M Wingerchuk; E F Wijdicks; J R Fulgham
Journal:  Cerebrovasc Dis       Date:  1998 Jan-Feb       Impact factor: 2.762

9.  Direct endovascular thrombolytic therapy for dural sinus thrombosis.

Authors:  S L Barnwell; R T Higashida; V V Halbach; C F Dowd; G B Hieshima
Journal:  Neurosurgery       Date:  1991-01       Impact factor: 4.654

10.  Venous sinus stenting for refractory benign intracranial hypertension.

Authors:  J Nicholas P Higgins; Brian K Owler; Claire Cousins; John D Pickard
Journal:  Lancet       Date:  2002-01-19       Impact factor: 79.321

View more
  1 in total

1.  Factors influencing therapy choice and clinical outcome in cerebral venous sinus thrombosis.

Authors:  Dagmar Krajíčková; Jiří Král; Roman Herzig; Ľudovít Klzo; Antonín Krajina; Jaroslav Havelka; Libor Šimůnek; Oldřich Vyšata; Tran Van Quang; Michal Bar; Martin Vališ
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.